nav.banner_textnav.banner_cta
Research Focus

Bone & Skeletal Health

A research overview of peptides targeting bone density, fracture repair, osteogenesis, and skeletal regeneration — mapping compounds to their mechanisms and key preclinical and clinical evidence.

Background

Why Peptides for Bone Health?

GH/IGF-1 Axis Drives Osteogenesis

Growth hormone and IGF-1 are the primary anabolic signals for osteoblast proliferation, bone matrix synthesis, and bone mineral density maintenance throughout life.

Collagen Matrix is 30% of Bone

Bone is not purely mineral — the organic collagen matrix provides tensile strength and flexibility. Peptides that stimulate collagen synthesis directly support bone quality.

Angiogenesis Required for Fracture Repair

Bone healing requires vascular ingrowth. VEGFR2 signalling drives new blood vessel formation into the fracture callus, a key mechanism of BPC-157.

Stem Cell Mobilization

Bone marrow progenitor cells must be recruited to sites of injury. Thymosin β4 and Epithalon support this mobilization, accelerating skeletal repair.

Compounds

Peptides Targeting Bone Health

Mechanisms

Key Research Pathways

GH/IGF-1 Axis

Growth hormone stimulates hepatic IGF-1 production. IGF-1 acts directly on osteoblasts to drive proliferation, differentiation, and bone matrix synthesis. This axis is the primary driver of bone density.

SermorelinIpamorelinCJC-1295IGF-1 LR3HGH 191AATesamorelin

Collagen & TGF-β

The organic bone matrix is 90% type I collagen. TGF-β signalling drives osteoblast differentiation and collagen synthesis. GHK-Cu directly activates this pathway.

GHK-CuBPC-157TB-500

Angiogenesis & VEGFR2

Fracture repair requires vascular ingrowth. VEGFR2 activation drives angiogenesis into the fracture callus, delivering oxygen and nutrients. BPC-157 is a potent VEGFR2 activator.

BPC-157GHK-Cu

Stem Cell Mobilization

Bone marrow contains mesenchymal stem cells that differentiate into osteoblasts. Mobilizing these progenitors to injury sites accelerates repair. Thymosin β4 and Epithalon support this process.

TB-500EpithalonMOTS-c
Literature

Key Studies in Bone Research

Rudman et al. (1990)N Engl J Med

Effects of Human Growth Hormone in Men over 60 Years Old

GH administration in aging men improved bone mineral density, lean body mass, and skin thickness. Foundational evidence for GH/IGF-1 axis in skeletal health.

Tomas et al. (1993)J Endocrinol

IGF-1 LR3 and Bone Protein Synthesis

IGF-1 LR3 increased bone protein synthesis and osteoblast activity, demonstrating the anabolic role of the IGF-1 receptor in skeletal tissue.

Sikiric et al. (2018)Curr Pharm Des

BPC-157 in Bone and Tendon Healing

BPC-157 accelerated bone and tendon healing in rodent models via VEGFR2 activation and osteoblast stimulation. Multiple fracture models showed improved repair.

Pickart et al. (2015)J Aging Res

GHK-Cu Collagen and Bone Matrix

GHK-Cu stimulated collagen synthesis and activated TGF-β signalling, supporting bone matrix quality and repair in aging tissue.

Johansen et al. (1999)Growth Horm IGF Res

Ipamorelin and Bone Growth

Ipamorelin, a selective GH secretagogue, increased bone mineral content and growth plate activity in growing rats without significant side effects.

Explore These Compounds

Browse the full catalog of research peptides available from SwissNova Labs.

View All Products